Literature DB >> 25405501

Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas.

M Lafont1, C Fagour, M Haissaguerre, G Darancette, T Wagner, J B Corcuff, A Tabarin.   

Abstract

CONTEXT: The per-operative hemodynamic behavior of normotensive incidentally discovered pheochromocytomas is poorly documented.
OBJECTIVE: To compare the per-operative hemodynamic instability and early postoperative outcome of normotensive pheochromocytomas, hypertensive pheochromocytomas, and benign non-pheochromocytoma adrenal incidentalomas (AIs).
DESIGN: Retrospective cohort treated in a single center. PATIENTS AND METHODS: Fifty patients (10 normotensive pheochromocytomas, 24 hypertensive pheochromocytomas, and 16 AIs) were anesthetized and operated on by the same team, using laparoscopy in 78% of cases. Before surgery, 60% of normotensive and 95.8% of hypertensive pheochromocytomas received pretreatment with α-receptor or calcium channel blockers. All of the patients received the same intraoperative hemodynamic monitoring, including continuous direct intra-arterial pressure recording.
RESULTS: All the features of hemodynamic instability, with the exception of the diastolic pressure nadir and fluid volume requirements, differed between hypertensive pheochromocytomas and AIs. Conversely, all features of hemodynamic instability were similar in hypertensive and normotensive pheochromocytomas. More specifically, by comparison with AIs, normotensive pheochromocytomas displayed higher maximal systolic pressure; more hypertensive, severe hypertensive, and hypotensive episodes; and a higher minimal heart rate, and also required more interventions to treat undesirable blood pressure elevations. Postoperative complications, all of which were mild, were more frequent in hypertensive pheochromocytomas than in normotensive pheochromocytomas (P < .03).
CONCLUSIONS: Normotensive pheochromocytomas have roughly comparable per-operative hemodynamic instability to hypertensive pheochromocytomas and differ markedly from non-pheochromocytoma AIs. It is therefore crucial to identify normotensive pheochromocytomas among AIs when surgery is scheduled and to apply the standard of care for pheochromocytoma anesthesia.

Entities:  

Mesh:

Year:  2014        PMID: 25405501     DOI: 10.1210/jc.2014-2998

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience.

Authors:  Cyrille Buisset; Carole Guerin; Pierre-Julien Cungi; Mickael Gardette; Nunzia-Cinzia Paladino; David Taïeb; Thomas Cuny; Frederic Castinetti; Frederic Sebag
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

2.  [Clinical analysis of 939 patients with adrenal lesions detected by abdominal computed tomography].

Authors:  Cun-Xia Fan; Jia-Jun Zhang; Ying-Ying Cai; Chun-Yan Wu; Shao-Zhou Zou; Yi-Kai Xu; Yao-Ming Xue; Mei-Ping Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

Review 3.  Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor.

Authors:  Marco Grasso; Marco Boscaro; Carla Scaroni; Filippo Ceccato
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-10

4.  Anesthetic management of a giant paraganglioma resection: a case report.

Authors:  WeiBing Wang; Hui Zhou; AiJiao Sun; JingBo Xiao; DongShu Wang; DaXiang Huang
Journal:  BMC Anesthesiol       Date:  2022-07-11       Impact factor: 2.376

5.  The use of telemedicine in the preoperative management of pheochromocytoma saves resources.

Authors:  Martin Joseph Heslin; Joe-Spencer Liles; Paulina Moctezuma-Velázquez
Journal:  Mhealth       Date:  2019-08-20

6.  Influence of secretory phenotype and preoperative preparation on surgical outcome in pheochromocytoma.

Authors:  Raluca Maria Furnica; Muhammad Muddaththir Dusoruth; Alexandre Persu; Damien Gruson; Michel Mourad; Dominique Maiter
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

7.  Tumor characteristics and surgical outcome in incidentally discovered pheochromocytomas and paragangliomas.

Authors:  Xinlei Chen; Liru Hu; Caojie Liu; Guangcheng Ni; Yuwei Zhang
Journal:  Endocr Connect       Date:  2018-09-01       Impact factor: 3.335

8.  Peri-operative management of pheochromocytoma with intravenous urapidil to prevent hemodynamic instability: A 17-year experience.

Authors:  Patrick Tauzin-Fin; Kévin Barrucand; Musa Sesay; Stéphanie Roullet; Philippe Gosse; Jean-Christophe Bernhard; Gregoire Robert; François Sztark
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-02-18

Review 9.  Preoperative Management of Pheochromocytoma and Paraganglioma.

Authors:  Fang Fang; Li Ding; Qing He; Ming Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

10.  A Predictive Nomogram for Red Blood Cell Transfusion in Pheochromocytoma Surgery: A Study on Improving the Preoperative Management of Pheochromocytoma.

Authors:  Ying Guo; Lili You; Huijun Hu; Anli Tong; Xiaoyun Zhang; Li Yan; Shaoling Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.